Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors: Levy, GG  Nichols, WC  Lian, EC  Foroud, T  McClintick, JN  McGee, BM  Yang, AY  Siemieniak, DR  Stark, KR  Gruppo, R  Sarode, R  Shurin, SB  Chandrasekaran, V  Stabler, SP  Sabio, H  Bouhassira, EE  Upshaw JD, JR  Ginsburg, D  Tsai, HM 
Citation: Levy GG, etal., Nature. 2001 Oct 4;413(6855):488-94.
Pubmed: (View Article at PubMed) PMID:11586351
DOI: Full-text: DOI:10.1038/35097008

Thrombotic thrombocytopenic purpura (TTP) is a life-threatening systemic illness of abrupt onset and unknown cause. Proteolysis of the blood-clotting protein von Willebrand factor (VWF) observed in normal plasma is decreased in TTP patients. However, the identity of the responsible protease and its role in the pathophysiology of TTP remain unknown. We performed genome-wide linkage analysis in four pedigrees of humans with congenital TTP and mapped the responsible genetic locus to chromosome 9q34. A predicted gene in the identified interval corresponds to a segment of a much larger transcript, identifying a new member of the ADAMTS family of zinc metalloproteinase genes (ADAMTS13). Analysis of patients' genomic DNA identified 12 mutations in the ADAMTS13 gene, accounting for 14 of the 15 disease alleles studied. We show that deficiency of ADAMTS13 is the molecular mechanism responsible for TTP, and suggest that physiologic proteolysis of VWF and/or other ADAMTS13 substrates is required for normal vascular homeostasis.

Annotation

Disease Annotations
Phenotype Annotations
Objects Annotated
Objects referenced in this article

Additional Information

 
CRRD Object Information
CRRD ID: 1598736
Created: 2006-12-16
Species: All species
Last Modified: 2006-12-16
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.